Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of OC-01 (varenicline) Nasal Spray in Dry Eye Disease (Japan)
jRCT2031250531Active, not recruiting
- Sponsor
- Viatris
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of varenicline in dry eye syndrome (DED), sponsored by Viatris. Started Dec 2025; status: active, not recruiting.
02
Drugs
varenicline
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2031250531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250531.